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Clonogenic Cell Subpopulations Maintain Congenital
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Christelle Charbel1,2,11, Romain H. Fontaine1,2,11, Natacha Kadlub3,4, Aurore Coulomb-L’Hermine2,5,
Thomas Rouille´1,2, Alexandre How-Kit6, Philippe Moguelet7, Jorg Tost6,8, Arnaud Picard3,4,
Selim Aractingi1,3,9,12 and Sarah Gue´gan1,2,10,12
Large congenital melanocytic nevi (lCMN) are benign melanocytic tumors associated with an increased risk of
melanoma transformation. They result predominantly from a post-zygotic somatic NRAS mutation. These lesions
persist and even increase after birth proportionally to the child’s growth. Therefore, we asked here whether cells
with clonogenic and tumorigenic properties persisted postnatally in lCMN. Subpopulations of lCMN cells
expressed stem cell/progenitor lineage markers such as Sox10, Nestin, Oct4, and ABCB5. In vitro, 1 in 250 cells
from fresh lCMN formed colonies that could be passaged and harbored the same NRAS mutation as the original
nevus. In vivo, lCMN specimens xenografted in immunocompromised mice expanded 4-fold. BrdUþ -proliferat-
ing and label-retaining melanocytes were found within the outgrowth skin tissue of these xenografts, which
displayed the same benign nested architecture as the original nevus. lCMN cell suspensions were not able to
expand when xenografted alone in Rag 2 / mice. Conversely, when mixed with keratinocytes, these cells
reconstituted the architecture of the human nevus with its characteristic melanocyte layout, lentiginous
hyperplasia, and nested architecture. Overall, our data demonstrate that, after birth, certain lCMN cell subtypes
still display features such as clonogenic potential and expand into nevus-like structures when cooperating with
adjacent keratinocytes.
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INTRODUCTION
Congenital melanocytic nevi (CMN) are benign melanocytic
tumors resulting from a neural crest–derived proliferation that
can infiltrate the epidermis, dermis, and hypodermis. These
nevi concern 1 in 20,000 births (Castilla et al., 1981). They
may have major medical and socio-aesthetic implications and
moreover a risk toward melanoma transformation. Projected
adult size remains the major criterion for classification
(Krengel et al., 2013). Large CMN (lCMN) are associated
with a higher risk of melanoma (Marghoob et al., 1996; Ruiz-
Maldonado, 2004; Krengel et al., 2006). Associated neuro-
logical abnormalities and tumors are also reported in these
patients (Kinsler et al., 2013b). Familial cases have rarely been
reported (de Wijn et al., 2010).
CMN are now considered to result predominantly from a
post-zygotic somatic NRAS or BRAF mutation, both mutations
being usually exclusive (Papp et al., 2005; Ichii-Nakato et al.,
2006; Bauer et al., 2007; Kinsler et al., 2013b; Charbel et al.,
2014). Indeed, exome sequencing analysis conducted on
lCMN samples by our group has shown that NRAS mutation
was the sole recurrent somatic mutation identified and there-
fore sufficient to drive nevus development (Charbel et al.,
2014). Cutaneous melanocytic cells are primarily derived from
the developing neural crest. In mouse, melanocytic precursor
cells migrate in the dorsolateral pathway (Mackenzie et al.,
1997; Jiao et al., 2006). Migration then continues ventrally
before the cells colonize the epidermis and developing hair
follicles (Grichnik, 2008).
Pathogenesis of nevi in humans remains uncompletely
understood. It was suggested that nevi could arise from bulge
melanocyte stem cells in mice (Krengel 2005; Nishikawa-
Torikai et al., 2011; Tanimura et al., 2011). Others have also
shown that transformed nerve sheath stem cells may lead to
formation of occult prenatal nevi (Cramer and Fesyuk, 2012).
Barnhill et al. have reported that embryonic stem cells from
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the neural crest may migrate along vessels and other tracks
through angiotropism, resulting in the genesis of CMN
(Barnhill et al., 2010). However, such stem cell populations
have not yet been isolated in humans. In CMN, the presence
of a unique NRAS somatic mutation suggests that these tumors
result from the development of a melanocytic clone. These
cells then populate subcutaneous, dermal, and epidermal
structures where they organize into a nevus (Grichnik,
2008). The analysis of transgenic mice in which constitu-
tively activated NRAS is restricted to the melanocyte lineage
also supports this hypothesis. Indeed, these mice develop
generalized, nevus-like dermal melanocytosis (Ackermann
et al., 2005). Altogether, these data support clonal prolife-
ration in CMN. Of note, after birth, CMN increase in surface
proportionally to the child’s growth. Such evolution suggests
postnatal potential for proliferation in CMN. Therefore, our
study aimed at characterizing nevocytic cells capable of
maintaining and propagating CMN.
RESULTS
Immunohistochemical and flow cytometric analyses indicate
the presence of minor lCMN populations expressing stem cell
markers
lCMN (n¼ 4 specimens) and superficial spreading melanoma
(SSM; n¼ 4) were compared (Figure 1). The lesions were
dissected in a gridded manner and various sectors analyzed
per lesion: the number of positive cells was counted and
reported to the total number of DAPIþ cells per percentage of
total cells per 100mm2 surface areas, both in the epidermis
and dermis (three per sector and per skin region).
The expression of melanocytic/melanoma marker such as
MITF and HMB45 was first analyzed. MITF staining in the
lesions demonstrated a higher level of differentiated melano-
cytic infiltrate in lCMN as compared with SSM (Figure 1a;
lCMN mean±SEM: 7.07±0.51; ***Pp0.0001). Both SSM and
lCMN harbored HMB45þ cells; these cells were predomi-
nantly found in the epidermis and upper dermis in lCMN with
a histochemical maturation (Supplementary Figure S1a online).
Neural crest stem cell marker expression was then eval-
uated. Sox10, a key regulator of pigment cell formation, is
expressed throughout all stages of melanocyte differentiation
(Sommer, 2011), as well as in CMN and melanoma (Shakhova
et al., 2012). Nestin is expressed in nevi and melanoma
(Sharma et al., 2010). In lCMN, Sox10 was predominantly
expressed in the dermis. When compared with SSM, a
significantly lower number of Sox10þ cells was found in
lCMN (Figure 1b; SSM mean±SEM: 7.69±0.75%; lCMN
mean±SEM: 5.34±0.53%; *Pp0.05). The fact that lCMN
harbor more MITFþ cells and less Sox10þ cells compared
with melanoma probably relates to a higher ratio of
differentiated cells in nevi. Nestin was highly expressed
both in lCMN and SSM without any statistical difference
(Figure 1c).
Oct4, an embryonic stem cell transcription factor mainly
associated with an undifferentiated phenotype and adult germ
cell tumors, may be expressed in the basal layer of human skin
epidermis and in melanoma (Tai et al., 2005; Cheli et al.,
2011). Oct4-MelanA double stainings were performed.
Oct4þMelan-Aþ cells were detected in both SSM and
lCMN without any statistical difference (Figure 1d).
Chemoresistance mediator ABCB5 is expressed in human
malignant melanoma initiating cells (Schatton et al., 2008;
MITF
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Figure 1. Human lCMN express initiating stem cell markers. Immuno-
histochemical stainings of superficial spreading melanoma (SSM) and human
large congenital melanocytic nevi (lCMN): MITF (a), Sox10 (b), Nestin(c),
Oct4/Melan-A (d), ABCB5/Melan-A (e), and KI67(f). MITFþ , ABCB5þ , KI67þ
cells were stained with brown/red AEC chromogen. Melan-Aþ and Sox10þ
cells were stained using Alexa488 secondary antibody. Oct4þ cells were
stained using Cy3 secondary antibody. Scale bar¼ 100mm. Histograms show
the number of positive cells per total cells in both the epidermis and dermis.
(lCMN n¼5; melanoma, n¼ 4). *Represents differences between SSM and
lCMN. Bars: SEM. *Pp0.05, **Pp0.001, ***Pp0.0001 in Student’s t-test.
Red dots delineate the edge of the lesions.
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Sharma et al., 2010). As expected, double staining revealed
a higher level of ABCB5þMelan-Aþ cells in SSM when
compared with lCMN (Figure 1e; SSM mean±SEM: 33.64±
6.33%; lCMN mean±SEM: 8.79±1.23%; ***Pp0.0001).
Expression of CD44, a well-accepted cancer stem cell surface
marker, has been reported in benign and malignant melano-
cytic lesions (Leigh et al., 1996). Here, benign lCMN as well
as malignant SSM were featured by a similar CD44 expression
(Supplementary Figure S1b online).
As expected, the number of proliferating cells estimated
through Ki67 labeling was strikingly lower in lCMN as com-
pared with SSM (Figure 1f; SSM mean±SEM: 13.66±1.03%;
lCMN mean±SEM: 8.64±0.69%; ***Pp0.0001). Of note, in
lCMN, Ki67 expression was intense and localized mostly to
the basal layer of the epidermis where melanocytes mainly
reside usually within nevocytic nests, indicating a proliferative
activity of melanocytes. This observation could possibly
explain why lCMN have a higher risk of transformation
compared with small congenital or acquired nevi.
In order to better evaluate the percentages of cells expres-
sing stem cell markers in lCMN, FACS was performed
on CD31CD45DAPI sorted lCMN cell suspensions.
Single-positive cells were present in these cell suspensions
with 2.97% ABCB5þ cells (Supplementary Figure S2a and b
online), 2.79% CD133þ cells, and 1.53% CD166þ cells
(Supplementary Figure S2b online). Neural crest nerve growth
factor Receptor CD271 expressed by human neural crest–
derived tissues can characterize human melanoma–initiating
cells (Boiko et al., 2010). CD271 expression has not been
previously reported in congenital nevi. In our study, 1.05% of
lCMN cells were CD271þ (Supplementary Figure S2a and b
online). There was no co-expression of these stem cell mar-
kers. Altogether, these immunostainings and flow cytometric
analyses demonstrate the presence within lCMN of cells
expressing several stem cell markers, thus reflecting lCMN
heterogeneity.
In vitro characteristics of spheroid colonies obtained from lCMN
Non-adherent cell culture using optimized sphere medium
was performed to better characterize the nevocytic cell
suspensions. Sphere-forming and clonogenic assays allow
evaluation of both cell self-renewal and differentiation at the
single-cell level (Schatton et al., 2008; Pastrana et al., 2011).
Melanospheres generated from primary melanoma and
melanoma cell lines have extensively been analyzed (Fang
et al., 2005; Perego et al., 2010; Cheli et al., 2011) and served
as controls in this study.
lCMN cell suspensions, primary melanoma cells, and
Mel501 melanoma cells were cultured in three different
optimized media: N2, B27, or B27þ insulin (See Materials
and Methods section for details). Primary and Mel501 mela-
noma cells and all lCMN cell suspensions (n¼5) gave rise to
spheroid colonies in the 3 media tested (Supplementary Figure
S3a online). The B27þ insulin medium was chosen as the most
adequate (Supplementary Figure S3b online). After 7 and 13
days of culture (DIV7 and DIV13), the number and size of
lCMN colonies were significantly lower as compared with
those of Mel501 colonies (***Pp0.0001 in Figure 2a), as
expected in a benign proliferation. Similar results were obtained
with primary melanoma colonies (Supplementary Figure S3b
online). Mel501 spheres showed a constant increase in size
and number between DIV7 and DIV13 (Figure 2a; yPp0.05,
yyyPp0.0001). On the other hand, lCMN colonies reached a
plateau on DIV7 and showed a very slight increase in their
number but not in their size between DIV7 and DIV13
(Figure 2a, yPp0.05; Supplementary Figure S3c online).
To further assert the replicative abilities of CMN spheres, these
were enzymatically dissociated on DIV13, replated de novo at
very low density in optimized sphere medium, and studied over
five passages in vitro. lCMN cells constantly formed spheres
after each passage (Figure 2b). A special care was given to cell
digestion, absence of aggregation being constantly verified at
each passage. Sphere number and diameter evaluated on DIV7
and 13 did not vary throughout the experiment (graphs in
Figure 2b). On DIV13, lCMN spheres expressed Melan-A as
well as the stem cell markers Nestin and Oct-4 (Figure 2c).
Melan-A and/or Nestin expression was also found in all adherent
cultured cells (Supplementary Figure S4a), showing that in vitro
culture allowed melanocyte selection. Of note, the percentages
of Melan-A-positive cells were previously evaluated on DIV0 (at
least 60% of Melan-Aþ cells; Supplementary Figure S4b online).
The percentage of lCMN cells giving rise to colonies
was calculated using an in vitro limiting dilution assay
(see Materials and Methods section and Liu et al., 2013).
The frequencies of cells displaying clonogenic potential
were 1 in 302 cells on DIV7 and 1 in 254 cells on DIV13,
respectively (n¼3 specimens; Figure 3a).
Soft agar colony formation assay that monitors anchorage-
independent growth was used in order to confirm sphere
clonality and assess anchorage-independent growth. On DIV
13, individually seeded lCMN cells were able to form colonies
in soft agar only when cultured in optimized sphere medium
(Supplementary Figure S4c online; photomicrographs in
Figure 3b). Colony diameters measured 60–70mm as in the
classical sphere forming assay (n¼5; graphs in Figure 2a and
b, and 3b). Therefore, lCMN harbored cells capable of
dividing and forming spheres, as well as soft agar colonies
at a frequency of one in 250 cells.
Finally, the NRAS mutational status of these spheroid
colonies was ascertained by pyrosequencing: NRAS exon 3
genotyping was performed on five lCMN specimens as well as
on the in vitro colonies arising after adequate culture of the
corresponding cell suspensions (Figure 3c). The in vitro
colonies always bore the same c.181C4A, p.Q61K or
c.182A4G, p.Q61R NRAS mutation as the original nevus.
Altogether, these data support the existence of NRAS-mutated
cells capable of clonal proliferation within lCMN.
In vivo potential to induce benign tumors
In order to assess the tumorigenic potential of the nevocytic
cells, xenotransplantations were performed using immuno-
compromised mice. Standardized specimens (3-mm punch
biopsies) of lCMN were xenografted in brown adipose tissue
in Rag2 / mice. Grafts were harvested 3 and 7 months post
transplantation, and tumor volume was measured (n¼8
grafted specimens; Figure 4a). Seven months post grafting,
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lCMN tissues had increased 4-fold when compared with the
original biopsies (graph in Figure 4a). Hematoxylin-eosin
staining (Figure 4b) revealed a xenograft architecture (‘‘grafted
nevus’’) similar to the original nevus (‘‘pregraft’’) and a
surrounding pigmented outgrowth tissue (‘‘graft neoepi.’’)
enclosing a cystic structure. Anti-human Melan-A and anti-
Sox10 labeling demonstrated in the grafted nevus as well as
in the developing neoepidermis the presence of human
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Melan-Aþ cells (Figure 4c) and Sox10þ cells (Figure 4d)
organized in melanocytic nests, thus reproducing the original
nevus structure. Double labeling with anti-human Melan-A/
anti-BrdU or anti-Sox10/anti-BrdU antibodies was performed
in mice that received a single BrdU injection 30 minutes
before euthanasia (n¼3 grafted specimens). In these grafted
nevi, Melan-Aþ /BrdUþ cells were present in both the grafted
part of the nevus and neoepidermis (Figure 4e). In another
group of mice in which BrdU was injected 1 month before
euthanasia, the presence of few human Sox10þ /BrdUþ cells
corresponding to Label-Retaining Cells (LRCs) could be con-
firmed (Figure 4f). Quantitations of double-positive cells did
not show any statistical difference between the grafted nevus
and the neoepidermis. Xenografts displayed 4.5% of Melan-
Aþ /BrdUþ -proliferating cells and 6.5% of Sox10þ /BrdUþ
label–retaining cells (Histograms in Figures 4e and f). The
percentage of Sox10þ /BrdUþ label–retaining melanocytes
was 4% (histogram in Supplementary Figure S5a online).
These data demonstrate the presence of quiescent melanocytic
cells within lCMN with features of label-retaining cells.
To fully determine the ability of these cells to reproduce a
nevus, other transplantation experiments using lCMN suspen-
sions were conducted. One million fresh nevocytic cell
suspensions were mixed with Matrigel then grafted into the
right flank of Rag2 / mice (n¼5 injections from five
specimens). Seven months post grafting, Matrigel was har-
vested. Inside the Matrigel, low numbers of DAPIþ cells and
very few isolated human Melan-A and Sox-10þ cells were still
detectable (Figure 5a, white arrows), indicating the persistence
of isolated long-term surviving human melanocytes. The
absence of nevi development in Matrigel injected with
nevocytes alone contrasted with the expanding grafted nevi.
This strongly encouraged us to evaluate melanocytes’ need for
another cell type in order to expand––namely keratinocytes.
To test this hypothesis, human non-tumorigenic keratino-
cytes (the HaCaT cell line) were mixed with the lCMN
cell suspension in order to mimic the required physio-
logical environment. Different concentrations of sorted
CD31 /CD45 cell suspensions (1.5 million, 5,00,000 and
4,00,000 cells) were injected with HaCaT keratinocytes into
100 100
75
50
37
25
0
75
50
37
25
0%
 N
eg
at
ive
 c
ul
tu
re
s 
DI
V7
%
 N
eg
at
ive
 c
ul
tu
re
s 
DI
V1
3
0 100
Number of plated cells
DIV 0
Ag
ar
Sample
1 4 mo Female Trunk
Trunk
Trunk
Trunk
Trunk
20–30 NRAS3
NRAS3
NRAS3
NRAS3
NRAS3
Q61K Q61K
Q61K
Q61R
Q61R
Q61R
NRAS3
NRAS3
NRAS3
NRAS3
NRAS3
Q61K
Q61R
Q61R
Q61R
20–30
10–20
40–60
20–30
Male
Male
Male
Female
5 y
4 mo
7 mo
3 mo
2
3
4
5
Age (months) Sex Tissue site PAS (cm)1 Nevus
mutation2
In vitro colonies
mutation2
DIV 13
200 300
302 254
400 500
80
60
40
20
0
DIV 3 DIV 5 DIV 7 DIV 9 DIV 13
D
ia
m
et
er
 o
f c
ol
on
ie
s 
(μm
)
0 100
Number of plated cells
200 300 400 500
Figure 3. In vitro characterization of large congenital melanocytic nevi (lCMN)-initiating cells: percentage of initiating cells and the soft agar assay. (a) lCMN
cells were plated with decreasing concentrations from 500–10 cells per well. Colony numbers were counted on DIV7 and 13 (n¼ 3 specimens). 1/302- and 1/254-
initiating cells were capable of forming colonies on DIV7 and 13, respectively. (b) Soft agar assay assessed on lCMN cells (n¼ 5). Individually seeded lCMN cells
were able to form colonies. Photomicrographs taken on DIV0 and DIV13 (left panel). Scale bar¼ 100mm. The histogram (right panel) represents the diameter of
colonies measured from DIV3 to DIV13. (c) Clinical and mutational characteristics of 5 lCMN and derived colonies. 1PAS, projected adult size; 2pyrosequencing
was used to screen NRAS exon 3 mutations.
C Charbel et al.
Clonogenic Cells in Large Congenital Nevi
828 Journal of Investigative Dermatology (2015), Volume 135
Matrigel at a ratio of one melanocyte for two keratinocytes
into the right flank of Rag2 / mice (n¼ 4 injections from
four specimens). In parallel, HaCaT cell suspensions were
injected in the left flank of mice and used as positive controls.
Interestingly, 3 months after xenotransplantation, a pigmented
tumor developed in the right flank of two of these four mice
(Supplementary Figure S5b online). These tumors mimicked
the morphology of a nevus, with an external layer of well-
organized keratinocytes, in which Melan-Aþ and Sox-10þ
cells were found (Figure 5b, white arrows). These melanocytic
cells migrated through the multilayered epithelial structure but
were mainly present in its basal layer following a lentiginous
pattern (Figure 5b, black arrowheads). Interestingly, some
melanocytes formed nests or theques (Figure 5b, black
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arrows), a histological feature characteristic of nevus archi-
tecture. In these epithelial tumors, cystic contents (Figure 5b,
black star), dependent on the keratinocyte activity,
were present. In order to confirm the proliferative ability
of these nevocytic cells, immunostaining using anti-Ki67
antibody was performed (Supplementary Figure S5c online).
No Ki67þ cells were found in Matrigel containing only
melanocytes. In contrast, Matrigel containing both melano-
cytes and keratinocytes displayed numerous Ki67þ cells.
Altogether, these results support the postnatal persistence of
lCMN cells retaining tumorigenic potential and displaying
features of propagating cells when cooperating with
keratinocytes.
DISCUSSION
We here report evidence for postnatal persistence of clono-
genic and tumorigenic nevi cells in CMN. Our immunostain-
ing results indicate heterogeneity in lCMN tissue with minor
cell populations expressing various stemness markers. We
confirmed by flow cytometry the expression of ABCB5,
CD166, and CD271 in a low number of lCMN cells. Two
recent studies also show that CMN cells express pluripotency
markers (Kinsler et al., 2013a; Shakhova et al., 2012).
However, these results do not give proof of a hierarchy
between cells. Of note, FACS analyses revealed that stem/
propagating cell markers such as ABCB5 or CD271 were
never co-expressed on the same cells conversely to what
has been reported in melanoma. In contrast, ABCB5 was
expressed on differentiated cells expressing Melan-A, as
already reported in melanoma (Frank et al., 2003, 2005;
Quintana et al., 2010; Schatton et al., 2010). These data also
indicate that in various types of melanocytic proliferations,
cell membrane phenotype may differ from normal melano-
cytes’ phenotype.
Proliferative and clonogenic abilities of postnatal lCMN
cells were then analyzed in vitro. We were able to demon-
strate such features as lCMN cells were able to grow in
spheres, could be passaged at least five times, and formed
colonies in soft agar. Interestingly, nevocytic cell proliferation
in sphere medium was significantly lower than that of
their melanoma counterparts. Moreover, nevus spheres tended
to reach a plateau in contrast with melanoma spheres, which
grew permanently. Such kinetics may indicate that nevus cells
have a limited ability to proliferate, followed by a possible
‘‘quiescence or senescence’’ phenomenon. Of note, the
soft agar assays yielded colonies only when optimized
sphere medium was used (Supplementary Figure S3d online).
There too, lCMN colony diameter remained unchanged bet-
ween DIV7 and DIV13, whereas fully transformed Mel501
melanoma cells formed continuously growing colonies.
Beyond clonality, growth in soft agar is usually considered
as evidence for transformation. However, normal diploid
cells such as articular chondrocytes are also capable of growth
in soft agar without any transforming event (Skantze et al.,
1985). All these data indicate that lCMN contain cells that
have the ability to grow clonally and give progeny in elective
conditions and that appear to be partially transformed. Indeed,
genotyping experiments showed that these cells harbored
an NRAS mutation, similar to the one found in the original
nevus. Overall, CMN colonies could be maintained for at
least 84 days in vitro. Similarly, tumor-propagating cells
have been reported in other benign cutaneous proliferations
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Figure 5. In vivo xenotransplantation of large congenital melanocytic nevi (lCMN) cells in immunocompromised mice. lCMN cell suspensions were grafted into
Rag2 / mice. (a) No tumor was formed after 7 months; Melan-A and Sox10þ cells persisted in the Matrigel (n¼ 5 injections from five specimens, white arrows).
Scale bar¼ 100mm. (b) lCMN cell suspensions were mixed with HaCaT keratinocytes and injected (n¼ 4 injections from four specimens). After 3 months,
hematoxylin–eosin staining revealed melanocytic theques (black arrows) and a lentiginous melanocytic hyperplasia (black arrowheads) within keratinocyte
cysts (black star). Scale bar¼200mm, except in theques and lentiginous hyperplasia hematoxylin–eosin stainings where scale bar¼ 100mm. Melanocytic cells
were visualized using anti-Melan-A and anti-Sox10 antibodies (Alexa 488 secondary antibodies; white arrows). Higher magnifications are shown for each staining.
Scale bar¼ 50mm.
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such as papilloma and hemangioma (Khan et al., 2008; Xu
et al., 2011; Lapouge et al., 2012).
Beyond in vitro studies, maintaining properties were studied
in vivo. Grafted biopsies from lCMN had expanded 4-fold in
immunosuppressed mice after 7 months. This increase
resulted from an outgrowth of additional nevus at the
periphery of the graft. These results indicate that a population
of ‘‘committed’’ propagating cells was responsible for the
expansion of a nevus-like structure. The presence of label-
retaining human melanocytes was found in the nevus out-
growth. Of note, Herlyn et al. grafted adult acquired nevi in
mice, and persistence of melanocytes was found only before
day 88 post grafting (Herlyn et al., 1986), whereas this was
constant after 7 months in our study. Herlyn’s data together
with ours suggest that long-standing tumorigenic cells are a
privilege of lCMN, probably because of differences in
mutational profile (Ichii-Nakato et al., 2006). Indeed, NRAS
mutation is a hallmark of lCMN as opposed to small/
intermediate CMN and acquired nevi that frequently harbor
a BRAF mutation (Charbel et al., 2014).
When seeded in Matrigel, melanoma cells are able to grow
in immunosuppressed mice even when injected at low or very
low numbers (Quintana et al., 2008; Boiko et al., 2010;
Perego et al., 2010). Applying this technique to lCMN cell
suspension disclosed a significant difference: a small minority
of cells from the initial nevi suspensions was able to persist
after several months without evidence of proliferation. These
cells appeared always as isolated and interspersed cells. The
difference of behavior in Rag2 / mice between isolated
melanocytes (in Matrigel) and nevus grafts prompted us to
question cooperation between nevi melanocytes and
keratinocytes. When a non-transformed human keratinocyte
cell line was co-injected with lCMN cell suspension
in Matrigel, a large and solid pigmented tumor developed.
These specimens showed a multilayered pigmented epithelial
structure containing proliferating melanocytes organized in
melanocytic nests or in a lentiginous pattern. Therefore, lCMN
contained cells capable of reconstituting a nevus-like structure
when mixed with keratinocytes. These results are in
accordance with an older study. The authors grafted on
athymic mice a CMN coculture of epidermal cells, including
melanocytes and keratinocytes, together with a fibroblast
matrix. Up to 34 weeks, melanocytes were present only in a
‘‘darkened’’ epidermis without true nests. However, after this
delay, the dermis presented many round multinucleated cells
corresponding to CMN reconstitution (Cooper et al., 1999).
These results suggested that melanocytic nests originated in
the epidermis and then migrated below. Our model of lCMN
suspensions mixed with keratinocytes has shown that
keratinocytes have a major role in melanocytic behavior in
nevi, allowing the development and maintenance of melano-
cytic nests. Mediators of this cross talk remain to be deter-
mined. Keratinocytes control melanocyte migratory properties
and dermal invasion potential by modulating E-cadherin
expression (Gontier et al., 2002, 2004). Moreover, keratino-
cytes have a role in maintaining the melanocyte reservoir.
The melanocyte stem cells reside in the hair follicle bulge–
subbulge area, the lower permanent portion of the hair
follicle, where they serve as a melanocyte reservoir for the
skin and hair pigmentation. There, they directly adhere to hair
follicle stem cells (Nishimura, 2011). Forced expression of
stem cell factor /KITL, which is constitutively expressed in the
human epidermis, in the basal epidermis of mice using the
Krt14 promoter allowed survival of melanocytes in mouse
epidermis (Kunisada et al., 1998). Certain inflammatory factors
such as leukotriene C4 also induce chronic growth stimulation
of human adult melanocytes (Medrano et al., 1993). On the
other hand, it has been shown that different fibroblast-secreted
melanogenic peptides could modulate melanocyte numbers in
monolayer cultures (Cario-Andre´ et al., 2006; Salducci et al.,
2014). In vitro results on monolayers and skin reconstructs,
using growth factors and conditioned medium suggested that
murine fibroblasts secrete soluble factors that can stimulate
normal human melanocytes. Medium from human fibroblasts
stressed by medium starvation could increase normal
melanocyte proliferation in vitro. Moreover, among these
growth factors, both human and murine stem cell factor
induced an increase in melanocyte numbers (Cario-Andre´
et al., 2006). Therefore, the role of fibroblasts as well as of
other epithelial and hematopoietic cells as potential promoters
of CMN tumor formation should also be investigated.
In conclusion, we demonstrated that lCMN contain a sub-
population of cells able to persist after birth, self-renew, and
induce a nevus-like structure when cooperating with kerati-
nocytes. This could explain nevus secondary resurgences,
which have been described by surgeons following nevus
excision, as well as the natural expansion of nevi during the
child growth. On the other hand, the genomic analysis of
these cells is in line with our previous report on the role of
NRAS mutation as driver mutation in these benign melanocy-
tic proliferations (Charbel et al., 2014). Future studies should
focus on better characterizing these lCMN propagating cells.
Finally, a clinical valorization is expected, as the isolated cells
could also serve as tools for drug screening in CMN and/or
melanoma.
MATERIALS AND METHODS
Details can be found in Supplementary Materials and Methods online.
Human tissue samples
The study was approved by the institutional independent ethics
committee (Comite´ de Protection des Personnes Ile de France Paris
V) and complied with the Declaration of Helsinki principles. Patients
and patients’ guardians gave their written informed consent prior to
participation. Human lCMN samples were obtained from the maxillo-
facial department of Armand Trousseau hospital. Seventeen patients
with compound lCMN whose ages varied between 2 months and 5
years were included prospectively in the study on the basis of
adequate clinical data. Classification was done using the projected
adult size of the largest lesion (Krengel et al., 2013). Four SSM from
Tenon Hospital were used as positive controls.
Immunohistochemistry
Sections of 5-mm thickness were labeled with the following anti-
bodies: anti-human MITF (1:250), anti-human Nestin (1:100), anti-
human ABCB5 (1:50), anti-human KI67 (1:100), anti-human Oct4
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(1:100), anti-human Melan-A (1:100), and anti-human Sox10
(1:100).
In vitro assays
Fresh nevocytic cell suspension deriving from patients were seeded,
passaged, and/or plated in soft agar at a density of 50,000 cells per
well in DMEM/F12 supplemented with EGF (20 ng ml 1), basic
fibroblast growth factor (40 ng ml 1), B27 supplement, and insulin
(5mg ml 1). Spheres were counted and the diameter was measured.
The number and frequency of initiating cells were determined using
limiting dilution analysis (Liu et al., 2013). For immunocytochemistry,
sphere colonies were stained with anti-Melan-A (1:100), anti-Oct4
(1:50), and anti-Nestin (1:100) antibodies.
DNA extraction and genotyping
Samples were screened for the c.181C4A, p.Q61K or c.182A4G,
p.Q61R NRAS mutation. DNA was extracted using standard techni-
ques and pyrosequencing performed as previously described (Charbel
et al., 2014).
In vivo assays
All animal experiments were performed according to approved
experimental protocols following European Community Council
guidelines. For lCMN tissue transplantations, standardized specimens
were xenografted in brown adipose tissue in Rag2 / mice. For
human nevocytic cell transplantations, CD31CD45 sorted cells
were resuspended in 25% of Matrigel either alone or mixed with
human keratinocyte cell line HaCat at a ratio of 1:2 and injected
subcutaneously into the flank of Rag2/ mice. Xenografts were
collected 3 months or 7 months after grafting. Xenografted mice
were given i.p injections of BrdU prior to euthanasia. BrdU labeling
was detected using anti-BrdU antibody (1:50).
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